Aurinia Pharmaceuticals Inc (AUP.TO)
AUP.TO on Toronto Stock Exchange
7.70CAD
16 Oct 2018
7.70CAD
16 Oct 2018
Change (% chg)
$0.22 (+2.94%)
$0.22 (+2.94%)
Prev Close
$7.48
$7.48
Open
$7.41
$7.41
Day's High
$7.75
$7.75
Day's Low
$7.41
$7.41
Volume
28,805
28,805
Avg. Vol
29,483
29,483
52-wk High
$9.10
$9.10
52-wk Low
$5.68
$5.68
Revenue & Earnings Per Share
| Revenue* | Earnings Per Share** | ||
|---|---|---|---|
| FY 2018 | Jun '18 | 0.03 | -0.186 |
| Mar '18 | 0.03 | -0.184 | |
| FY 2017 | Dec '17 | 0.03 | -0.040 |
| Sep '17 | 0.03 | -0.157 | |
| Jun '17 | 0.33 | -0.029 | |
| Mar '17 | 0.03 | -0.916 | |
| FY 2016 | Dec '16 | 0.03 | -0.207 |
| Sep '16 | 0.03 | -0.206 | |
| Jun '16 | 0.05 | -0.101 | |
| Mar '16 | 0.06 | -0.132 |
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars
Consensus Estimates Analysis
| # of Estimates | Mean | High | Low | 1 Year Ago | |
|---|---|---|---|---|---|
| SALES (in millions) | |||||
| Quarter Ending Dec-18 | 2 | 0.07 | 0.10 | 0.03 | -- |
| Year Ending Dec-18 | 2 | 0.21 | 0.30 | 0.12 | 0.31 |
| Year Ending Dec-19 | 3 | 0.15 | 0.20 | 0.12 | 0.12 |
| Earnings (per share) | |||||
| Quarter Ending Dec-18 | 2 | -0.16 | -0.11 | -0.20 | -- |
| Year Ending Dec-18 | 3 | -0.69 | -0.62 | -0.76 | -0.58 |
| Year Ending Dec-19 | 4 | -0.64 | -0.45 | -0.88 | -0.57 |
Sales and Profit Figures in US Dollar (USD);
Valuation Ratios
| Company | industry | sector | ||
|---|---|---|---|---|
| P/E Ratio (TTM) | -- | 86.20 | 32.69 | |
| P/E High - Last 5 Yrs. | -- | 290.01 | 45.21 | |
| P/E Low - Last 5 Yrs. | -- | 90.56 | 23.82 | |
| Beta | 2.13 | 0.93 | 0.88 | |
| Price to Sales (TTM) | 1,306.17 | 123.88 | 5.82 | |
| Price to Book (MRQ) | 3.08 | 15.34 | 4.90 | |
| Price to Tangible Book (MRQ) | 3.36 | 14.54 | 6.53 | |
| Price to Cash Flow (TTM) | -- | 70.75 | 22.98 | |
| % Owned Institutions | -- | 13.94 | 2.14 | |
Dividends
| Company | industry | sector | ||
|---|---|---|---|---|
| Dividend Yield | -- | 0.34 | 1.51 | |
| Dividend Yield - 5 Year Avg | -- | 0.24 | 1.52 | |
| Dividend 5 Year Growth Rate | -- | 2.56 | 5.38 | |
| Payout Ratio(TTM) | -- | 16.91 | 43.96 | |
Growth Rates
| Company | industry | sector | ||
|---|---|---|---|---|
| Sales (MRQ) vs Qtr. 1 Yr. Ago | 498.18 | 391.55 | 7.73 | |
| Sales (TTM) vs TTM 1 Yr. Ago | 86.28 | 73.89 | 5.32 | |
| Sales - 5 Yr. Growth Rate | -28.98 | 30.83 | 9.89 | |
| EPS (MRQ) vs Qtr. 1 Yr. Ago | 71.27 | 24.83 | 22.57 | |
| EPS (TTM) vs TTM 1 Yr. Ago | -161.99 | -- | -- | |
| EPS - 5 Yr. Growth Rate | -- | 37.95 | 10.95 | |
| Capital Spending - 5 Yr. Growth Rate | -53.80 | 38.70 | 14.94 | |
Financial Strength
| Company | industry | sector | |
|---|---|---|---|
| Quick Ratio (MRQ) | -- | 1.94 | 2.25 |
| Current Ratio (MRQ) | 53.07 | 5.32 | 3.05 |
| LT Debt to Equity (MRQ) | 0.00 | 35.04 | 12.63 |
| Total Debt to Equity (MRQ) | 0.00 | 36.85 | 16.96 |
| Interest Coverage (TTM) | -- | -97.99 | 37.54 |
Profitability Ratios
| Company | industry | sector | ||
|---|---|---|---|---|
| Gross Margin (TTM) | 99.29 | 40.03 | 54.92 | |
| Gross Margin - 5 Yr. Avg. | 98.72 | 49.23 | 52.45 | |
| EBITD Margin (TTM) | -7,859.62 | -- | -- | |
| EBITD - 5 Yr. Avg | -847.60 | -574.53 | 11.10 | |
| Operating Margin (TTM) | -8,206.41 | -770.03 | 4.36 | |
| Operating Margin - 5 Yr. Avg. | -984.31 | -594.78 | 6.45 | |
| Pre-Tax Margin (TTM) | -16,648.93 | -731.81 | 5.41 | |
| Pre-Tax Margin - 5 Yr. Avg. | -996.77 | -600.11 | 6.89 | |
| Net Profit Margin (TTM) | -16,648.93 | -732.73 | 1.68 | |
| Net Profit Margin - 5 Yr. Avg. | -946.52 | -603.07 | 3.14 | |
| Effective Tax Rate (TTM) | -- | 23.70 | 23.23 | |
| Effective Tax Rate - 5 Yr. Avg. | -- | 18.84 | 24.11 | |
Efficiency
| Company | industry | sector | ||
|---|---|---|---|---|
| Revenue/Employee (TTM) | 26,384 | 22,887,281 | 812,879,200 | |
| Net Income/Employee (TTM) | -4,392,666 | 1,727,321 | 95,609,515 | |
| Receivable Turnover (TTM) | 2.52 | 19.88 | 5.78 | |
| Inventory Turnover (TTM) | -- | 2.39 | 3.60 | |
| Asset Turnover (TTM) | 0.00 | 0.40 | 0.92 | |
Management Effectiveness
| Company | industry | sector | ||
|---|---|---|---|---|
| Return on Assets (TTM) | -58.90 | -0.96 | 10.94 | |
| Return on Assets - 5 Yr. Avg. | -49.46 | 3.30 | 12.05 | |
| Return on Investment (TTM) | -60.83 | 0.73 | 14.32 | |
| Return on Investment - 5 Yr. Avg. | -57.68 | 2.37 | 15.66 | |
| Return on Equity (TTM) | -70.80 | 1.82 | 16.04 | |
| Return on Equity - 5 Yr. Avg. | -85.46 | 3.23 | 16.92 | |
| 1 Year | 3 Year | 5 Year | |
|---|---|---|---|
| Sales % | -26.38 | -43.69 | -28.98 |
| EPS (TTM) % | -14.09 | -- | -- |
| Dividend % | -- | -- | -- |
Note: Units in Millions of US Dollars
Performance for Aurinia Pharmaceuticals Inc
| Period | % Actual |
% vs. S&P 500 |
Rank In Industry |
Industry Rank |
|---|---|---|---|---|
| 4 Week | 1.10 | -3.68 | 94 | 60 |
| 13 Week | 0.73 | -3.76 | 99 | 64 |
| 26 Week | -12.39 | -12.73 | 77 | 77 |
| 52 Week | 22.88 | 14.03 | 99 | 47 |
| YTD | 192.23 | 184.04 | 99 | 56 |
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.
Institutional Holders
| % Shares Owned: | 28.39% |
| # of Holders: | 86 |
| Total Shares Held: | 24,222,289 |
| 3 Mo. Net Change: | -59,909 |
| # New Positions: | 0 |
| # Closed Positions: | 2 |
| # Increased Positions: | 2 |
| # Reduced Positions: | 4 |
| # Net Buyers: | -2 |
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.